Skip to content

Clinical trials

Terminated Lymphoma trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma Status: Terminated Country / region: South Korea Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20111
20131
20171
20182
20191
20202
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated10

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer2
ADC Therapeutics S.A.1
Calithera Biosciences, Inc1
Celgene1
EMD Serono Research & Development Institute, Inc.1
Eisai Inc.1
IGM Biosciences, Inc.1
Mirna Therapeutics, Inc.1
Sanofi1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma10
Recurrence3
Lymphoma, Large B-Cell, Diffuse2
Lymphoma, Non-Hodgkin2
Melanoma2
Breast Neoplasms1
Carcinoma, Hepatocellular1
Carcinoma, Renal Cell1
Central Nervous System Neoplasms1
Colorectal Neoplasms1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.